Evidence map›Paper›PMID 24455243›Full record

ArticleJournal of signal transduction2013

Upregulation of voltage-gated calcium channel cav1.3 in bovine somatotropes treated with ghrelin.

V M Salinas Zarate, A Magdaleno Méndez, B Domínguez Mancera, A Rodríguez Andrade, M Barrientos Morales, P Cervantes Acosta, A Hernández Beltrán, D Romero Salas, J L V Flores Hernández, E Monjaraz Guzmán and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of signal transduction, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

V M Salinas ZarateLaboratory of Cell Biology, School of Veterinary Medicine and Animal Science, University of Veracruz, Veracruz, Mexico.
A Magdaleno MéndezLaboratory of Cell Biology, School of Veterinary Medicine and Animal Science, University of Veracruz, Veracruz, Mexico.
B Domínguez ManceraLaboratory of Cell Biology, School of Veterinary Medicine and Animal Science, University of Veracruz, Veracruz, Mexico.
A Rodríguez AndradeDepartment of Chemistry and Biochemistry, Veracruz Institute of Technology, Mexico.
M Barrientos MoralesLaboratory of Cell Biology, School of Veterinary Medicine and Animal Science, University of Veracruz, Veracruz, Mexico.
P Cervantes AcostaLaboratory of Cell Biology, School of Veterinary Medicine and Animal Science, University of Veracruz, Veracruz, Mexico.
A Hernández BeltránLaboratory of Cell Biology, School of Veterinary Medicine and Animal Science, University of Veracruz, Veracruz, Mexico.
D Romero SalasLaboratory of Cell Biology, School of Veterinary Medicine and Animal Science, University of Veracruz, Veracruz, Mexico.
J L V Flores HernándezLaboratory of Neuroendocrinology, Institute of Physiology, University of Puebla, Puebla, Mexico.
E Monjaraz GuzmánLaboratory of Neuroendocrinology, Institute of Physiology, University of Puebla, Puebla, Mexico.
D R Félix GrijalvaDepartment of Cell Biology, Center for Research and Advanced Studies, National Polytechnic Institute, Mexico City, Mexico.
Universidad Veracruzana · MXUniversidad de Puebla · MXInstituto Politécnico Nacional · MXInstituto Tecnologico de Veracruz · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation of the growth hormone (GH) secretagogue receptor (GHS-R) by synthetic GH releasing peptides (GHRP) or its endogenous ligand (Ghrelin) stimulates GH release. Though much is known about the signal transduction underlying short-term regulation, there is far less information on the mechanisms that produce long-term effects. In the current report, using an enzyme-linked immunosorbent assay for GH detection and whole-cell patch-clamp recordings, we assessed the long-term actions of such regulatory factors on voltage-activated Ca(2+) currents in bovine somatotropes (BS) separated on a Percoll gradient and detected by immunohistochemistry. After 24 h of treatment with Ghrelin (10 nM) or GHRP-6 (100 nM) enhanced BS secretory activity; GH secretion stimulated by GHS through the activation of GHS-R because treatment with the antagonist of GHS-R (D-Lys3-GHRP-6, 10 μM) blocked the GH secretion, and the effect was dose and time dependent (24, 48, and 72 h). GH secretion stimulated by GHRP-6 was abolished by nifedipine (0.5 μM), a blocker of L-type HVA Ca(2+) channels, and KN-62 (10 μM), an inhibitor of Ca(2+)/CaM-KII. After 72 h in culture, all recorded BS exhibited two main Ca(2+) currents: a low voltage-activated (LVA; T-type) and a high voltage-activated (HVA; mostly dihydropyridine-sensitive L-type) current. Interestingly, HVA and LVA channels were differentially upregulated by Ghrelin. Chronic treatment with the GHS induced a significant selective increase on the Ba(2+) current through HVA Ca(2+) channels, and caused only a small increase of currents through LVA channels. The stimulatory effect on HVA current density was accompanied by an augment in maximal conductance with no apparent changes in the kinetics and the voltage dependence of the Ca(2+) currents, suggesting an increase in the number of functional channels in the cell membrane. Lastly, in consistency with the functional data, quantitative real-time RT-PCR revealed transcripts encoding for the Cav1.2 and Cav1.3 pore-forming subunits of L-type channels. The treatment with Ghrelin significantly increased the Cav1.3 subunit expression, suggeting that the chronic stimulation of the GHS receptor with Ghrelin or GHRP-6 increases the number of voltage-gated Ca(2+) channels at the cell surface of BS.

Identifiers

PMID24455243
PMCPMC3880704
OpenAlexW2033595669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.